TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
OGN

Organon & Co

Healthcare · Drug Manufacturers - General

13.70$ +0.0% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Cash Flow

Organon & Co (OGN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at 700 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow OGN
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
3,419 3,687 2,767 2,187 2,458 858 799 939 700
1,973 1,673 333 142 195 212 236 277 361
56 56 41 40 59 75 101 105 77
1,131 35 107 67 210 181
-1,435 -174 -672 -197 702 -452 -155 -278 -247
86 101 92 278 488 427 261 351 162
-56 -69 -102 -258 -481 -420 -260 -513 -390
145 145 145 145 290 294 297 88
-11 -17 -22
-4.0 59 -44 1,165 7,728 -108 -258 -11 -458
-3,372 -4,164 -2,621 -2,175 -1,333 -433 -569 -368 -561
-45 -527 75 -249 667 -31 -13 -18 -101
3,333 3,586 2,675 1,909 1,970 431 538 588 538

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?